Bristol-Myers Squibb Co.

NYSE:BMY   3:59:59 PM EDT
56.93
-1.43 (-2.45%)
4:00:00 PM EDT: $56.93 0.00 (0.00%)
Products

U.S. FDA Says Approves Bristol-Myers Squibb's Cell-Based Gene Therapy For Adult Patients With Multiple Myeloma

Published: 03/27/2021 14:10 GMT
Bristol-Myers Squibb Co. (BMY) - FDA Approves First Cell-based Gene Therapy for Adult Patients With Multiple Myeloma.